SCHEMBL329049

SCHEMBL329049

CC(CCc1ccc(O)cc1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 7/20 0.71
▸ PPARG P37231 3/20 0.68
▸ PPARD Q03181 3/20 0.68
▸ PPARA Q07869 3/20 0.68
▸ SYNJ2 O15056 2/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ MAPT P10636 2/20 0.54
▸ ABL1 P00519 1/20 0.54
▸ ALPL P05186 1/20 0.54
▸ POLB P06746 1/20 0.54
▸ ALPI P09923 1/20 0.54
▸ GAA P10253 1/20 0.54
▸ ALPG P10696 1/20 0.54
▸ PABPC1 P11940 1/20 0.54
▸ RECQL P46063 1/20 0.54
▸ GALK1 P51570 1/20 0.54
▸ CASP7 P55210 1/20 0.54
▸ CASP6 P55212 1/20 0.54
▸ MCL1 Q07820 1/20 0.54
▸ RIN1 Q13671 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28971367 1.00 TYR (0.71) TYRPPARGPPARDPPARASYNJ2
SCHEMBL16234564 1.00 TYR (0.71) TYRPPARGPPARDPPARASYNJ2
SCHEMBL5320094 1.00 TYR (0.71) TYRPPARGPPARDPPARASYNJ2
SCHEMBL16233068 1.00 TYR (0.71) TYRPPARGPPARDPPARASYNJ2
SCHEMBL16167402 0.89 SYNJ2 (0.67) TYRPPARGPPARDPPARASYNJ2
SCHEMBL18821488 0.87 TYR (0.61) TYRPPARGPPARDPPARASYNJ2
SCHEMBL4652451 0.80 TYR (0.61) TYRPPARGPPARDPPARAKDM4E
SCHEMBL28707080 0.79 PPARG (0.60) TYRPPARGPPARDPPARASYNJ2
SCHEMBL27718878 0.79 PPARG (0.63) TYRPPARGPPARDPPARASYNJ2
SCHEMBL28007620 0.79 PPARG (0.60) TYRPPARGPPARDPPARASYNJ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994083-A Application of azalea essence and derivatives thereof in preparation of iron death inhibitor 山西医科大学 2024-11-22 — — CN claimed
EP-4267103-A1 PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION Oriflame Cosmetics AG (CH) 2023-11-01 — — EP claimed
WO-2022135827-A1 PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION ORIFLAME COSMETICS AG (CH) 2022-06-30 — — WO claimed
CN-114470087-A External essence with special effect for treating neck, shoulder, waist and leg pain 许宗魁 2022-05-13 — — CN claimed
CN-112089745-B Processing method of rhododendron molle and rhododendron molle decoction pieces 重庆市中医院 2022-03-15 — — CN claimed
CN-112089745-A Processing method of rhododendron molle and rhododendron molle decoction pieces 重庆市中医院 2020-12-18 — — CN claimed
CN-110372767-A The method extracted from Rhododendron pizewalskii leaf and separate betuloside 西北师范大学 2019-10-25 — — CN claimed
CN-107033198-A A kind of separation method of pine needle chemical composition 成都康弘制药有限公司 2017-08-11 — — CN claimed
US-20140336135-A1 NOVEL USE OF RHODODENDRIN CATHOLIC UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) 2014-11-13 — — US claimed
US-6184367-B1 SIMPLE AND COST EFFICIENT METHOD WHICH AVOIDS CHROMATOGRAPHIC METHODS; DEFATTING LEAVES, SOLVENT EXTRACTION, THEN TO EACH PHASE CONCENTRATING, TREATING WITH ALKALI, ACIDIFYING, AND SOLVENT EXTRACTION; ISOLATION OF BETULIGENOL AND BETULOSIDE COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2001-02-06 — — US claimed
CN-1189365-A Medicine for preventing Aids virus, treponema pallidum, neisseria gonorrhoeae and trichomonad LEI XUEJUN (CN) 1998-08-05 — — CN claimed
EP-0707072-A1 Preparation of raspberry-like ketones by bioconversion BFA LABORATOIRES (FR) 1996-04-17 — — EP claimed
JP-1051068-A — — None — — JP disclosed
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 — — US disclosed
EP-4593631-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME Mars, Incorporated (US) 2025-08-06 — — EP disclosed
CN-120131625-A Application of azalea essence in preparation of intestinal microecological regulator and colorectal cancer treatment medicine 常州市第二人民医院 2025-06-13 — — CN disclosed
EP-1062357-A1 RASPBERRY KETONE BIOCONVERSION PERNOD-RICARD (FR) 2000-12-27 — — EP disclosed
WO-1999049069-A1 RASPBERRY KETONE BIOCONVERSION PERNOD RICARD (FR) 1999-09-30 — — WO disclosed
EP-0707072-A1 Preparation of raspberry-like ketones by bioconversion BFA LABORATOIRES (FR) 1996-04-17 — — EP disclosed
JP-S6451068-A PREPARATION OF TEA FROM ACER NIKOENSIS TOYO KAGAKU KK 1989-02-27 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336135-A1 NOVEL USE OF RHODODENDRIN TLR1, IFNG, ROS1 TYR 63/4885PPARG 475/4885PPARD 213/4885
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL TYR 446/4885PPARG 883/4885PPARD 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback